Use of selective antagonists of the .alpha.1B-adrenergic receptor for improvement of sexual dysfunction
US6303606A · kind A · utility
16Cited by
8References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 2000 |
| Grant date | Oct 16, 2001 |
| Priority date | — |
| Expiry date | May 5, 2020 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described is the use in the treatment of either male or female sexual dysfunction of selective antagonists of the .alpha..sub.1B -adrenergic receptor and the pharmaceutical compositions containing them as compounds capable of helping the sexual act avoiding at the same time excessive side effects due to acute hypotension.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.